Jonathan H. Kaufman
See remarks below., Director, 10% Owner · LIPELLA PHARMACEUTICALS INC.
Individual
- 2024
- Dec 27, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jonathan H. Kaufman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $83.13M in VOR purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan H. Kaufman?
Jonathan H. Kaufman is a corporate insider, tracked as See remarks below., Director, 10% Owner of LIPELLA PHARMACEUTICALS INC. (LIPO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jonathan H. Kaufman last file a Form 4?
The only primary Form 4 on record is dated 27 December 2024.